An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
One in five Canadians will have heart failure
A disease misunderstood by the general population
A Canadian first for new implantable technology
Latest advances in mechanical circulatory support